Your browser doesn't support javascript.
loading
Utilization and Impact of Symptomatic and Exposure SARS-CoV-2 Testing in K-12 Schools.
Schuster, Jennifer E; Erickson, Tyler R; Goldman, Jennifer L; Benjamin, Daniel K; Brookhart, M Alan; Dewhurst, Stephen; Fist, Alex; Foxe, John; Godambe, Maya; Gwynn, Lisa; Kiene, Susan M; Keener Mast, Dana; McDaniels-Davidson, Corinne; Newland, Jason G; Oren, Eyal; Selvarangan, Rangaraj; Shinde, Nidhi; Walsh, Tyler; Watterson, Treymayne; Zand, Martin; Zimmerman, Kanecia O; Kalu, Ibukunoluwa C.
Afiliação
  • Schuster JE; Division of Pediatric Infectious Diseases.
  • Erickson TR; School of Medicine, Duke University, Durham, North Carolina.
  • Goldman JL; Division of Pediatric Infectious Diseases.
  • Benjamin DK; Duke Clinical Research Institute.
  • Brookhart MA; Department of Pediatrics.
  • Dewhurst S; School of Medicine, Duke University, Durham, North Carolina.
  • Fist A; Department of Microbiology and Immunology.
  • Foxe J; Duke Clinical Research Institute.
  • Godambe M; Department of Neuroscience.
  • Gwynn L; Division of Pediatric Infectious Diseases, Washington University in St Louis, St Louis, Missouri.
  • Kiene SM; Department of Pediatrics, Miller School of Medicine, University of Miami, Miami, Florida.
  • Keener Mast D; Division of Epidemiology and Biostatistics, School of Public Health, San Diego State University, San Diego, California.
  • McDaniels-Davidson C; ICF International. Inc, Atlanta, Georgia.
  • Newland JG; Division of Epidemiology and Biostatistics, School of Public Health, San Diego State University, San Diego, California.
  • Oren E; Division of Pediatric Infectious Diseases, Washington University in St Louis, St Louis, Missouri.
  • Selvarangan R; Division of Epidemiology and Biostatistics, School of Public Health, San Diego State University, San Diego, California.
  • Shinde N; Pathology and Laboratory Medicine, Children's Mercy Kansas City, University of Missouri-Kansas City, Kansas City, Missouri.
  • Walsh T; Division of Pediatric Infectious Diseases, Washington University in St Louis, St Louis, Missouri.
  • Watterson T; Division of Pediatric Infectious Diseases, Washington University in St Louis, St Louis, Missouri.
  • Zand M; Division of Pediatric Infectious Diseases, Washington University in St Louis, St Louis, Missouri.
  • Zimmerman KO; Division of Nephrology, School of Medicine and Dentistry, University of Rochester, Rochester, New York.
  • Kalu IC; School of Medicine, Duke University, Durham, North Carolina.
Pediatrics ; 152(Suppl 1)2023 07 01.
Article em En | MEDLINE | ID: mdl-37394504
ABSTRACT

OBJECTIVES:

The Centers for Disease Control and Prevention recommend that schools can offer severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostic (on-demand) testing for students and staff with coronavirus disease 2019 symptoms or exposures. Data related to the uptake, implementation, and effect of school-associated on-demand diagnostic testing have not been described.

METHODS:

The Rapid Acceleration of Diagnostics Underserved Populations Return to School program provided resources to researchers to implement on-demand SARS-CoV-2 testing in schools. This study describes the strategies used and uptake among the different testing programs. Risk of positivity was compared for symptomatic and exposure testing during the δ and ο variant periods. We estimated the number of school absence days saved with school-based diagnostic testing.

RESULTS:

Of the 16 eligible programs, 7 provided school-based on-demand testing. The number of persons that participated in these testing programs is 8281, with 4134 (49.9%) receiving >1 test during the school year. Risk of positivity was higher for symptomatic testing compared with exposure testing and higher during the ο variant predominant period compared with the δ variant predominant period. Overall, access to testing saved an estimated 13 806 absent school days.

CONCLUSIONS:

School-based on-demand SARS-CoV-2 testing was used throughout the school year, and nearly half the participants accessed testing on more than 1 occasion. Future studies should work to understand participant preferences around school-based testing and how these strategies can be used both during and outside of pandemics.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Pediatrics Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Pediatrics Ano de publicação: 2023 Tipo de documento: Article